| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 14 | 2026 | 692 | 3.040 |
Why?
|
| Macrophages | 57 | 2018 | 1507 | 2.890 |
Why?
|
| Pulmonary Fibrosis | 19 | 2026 | 395 | 2.630 |
Why?
|
| Lung | 32 | 2026 | 4106 | 2.210 |
Why?
|
| Fibroblasts | 18 | 2026 | 1025 | 2.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 34 | 2014 | 1217 | 2.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 13 | 2005 | 162 | 1.870 |
Why?
|
| Apoptosis | 22 | 2026 | 2440 | 1.750 |
Why?
|
| Bleomycin | 16 | 2026 | 255 | 1.660 |
Why?
|
| fas Receptor | 7 | 2020 | 91 | 1.340 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 14 | 2010 | 80 | 1.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2026 | 239 | 1.260 |
Why?
|
| Antigens, CD | 12 | 2004 | 558 | 1.260 |
Why?
|
| Signal Transduction | 28 | 2026 | 5216 | 1.200 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 11 | 2005 | 171 | 1.160 |
Why?
|
| Arthritis, Experimental | 3 | 2018 | 136 | 1.140 |
Why?
|
| Mice | 87 | 2026 | 18329 | 1.090 |
Why?
|
| Macrophages, Alveolar | 10 | 2014 | 373 | 1.060 |
Why?
|
| Insulin-Like Growth Factor I | 10 | 2009 | 317 | 1.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 9 | 1999 | 165 | 0.960 |
Why?
|
| Mitogen-Activated Protein Kinases | 12 | 2004 | 288 | 0.940 |
Why?
|
| Animals | 100 | 2026 | 38030 | 0.910 |
Why?
|
| Nitric Oxide Synthase | 6 | 2001 | 234 | 0.860 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 10 | 2002 | 126 | 0.840 |
Why?
|
| Alveolar Epithelial Cells | 6 | 2025 | 121 | 0.810 |
Why?
|
| Mice, Inbred C3H | 30 | 2005 | 254 | 0.780 |
Why?
|
| Trans-Activators | 4 | 2015 | 396 | 0.770 |
Why?
|
| Myofibroblasts | 3 | 2026 | 148 | 0.770 |
Why?
|
| Lung Injury | 3 | 2019 | 244 | 0.730 |
Why?
|
| Interferon-gamma | 14 | 2010 | 784 | 0.720 |
Why?
|
| Collagen | 6 | 2018 | 457 | 0.700 |
Why?
|
| Indoles | 3 | 2026 | 507 | 0.700 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 11 | 2011 | 153 | 0.670 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 8 | 0.670 |
Why?
|
| Pulmonary Emphysema | 1 | 2024 | 277 | 0.670 |
Why?
|
| Epithelial Cells | 9 | 2023 | 1131 | 0.660 |
Why?
|
| TRPC Cation Channels | 2 | 2010 | 14 | 0.650 |
Why?
|
| Immunity, Innate | 4 | 2018 | 835 | 0.640 |
Why?
|
| Cells, Cultured | 29 | 2020 | 4148 | 0.600 |
Why?
|
| Macrophage Activation | 11 | 2009 | 181 | 0.550 |
Why?
|
| NF-kappa B | 7 | 2009 | 666 | 0.550 |
Why?
|
| Pneumonia | 6 | 2018 | 636 | 0.530 |
Why?
|
| MAP Kinase Kinase 4 | 5 | 2002 | 23 | 0.500 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 919 | 0.490 |
Why?
|
| Interleukin-4 | 4 | 2008 | 207 | 0.490 |
Why?
|
| Disease Models, Animal | 9 | 2026 | 4560 | 0.480 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2023 | 664 | 0.480 |
Why?
|
| Cell Line | 16 | 2019 | 2823 | 0.470 |
Why?
|
| Lipopolysaccharides | 9 | 2012 | 858 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 21 | 2026 | 5983 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 9 | 2020 | 474 | 0.450 |
Why?
|
| Mice, Knockout | 14 | 2020 | 3124 | 0.440 |
Why?
|
| Serum Response Factor | 1 | 2015 | 33 | 0.440 |
Why?
|
| TNF Receptor-Associated Factor 2 | 4 | 2010 | 8 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 1999 | 431 | 0.430 |
Why?
|
| Monocytes | 7 | 2018 | 539 | 0.430 |
Why?
|
| Mesoderm | 1 | 2015 | 147 | 0.410 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2026 | 280 | 0.400 |
Why?
|
| Interleukin-8 | 6 | 2009 | 269 | 0.400 |
Why?
|
| Sodium Chloride | 2 | 2006 | 138 | 0.400 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 1180 | 0.390 |
Why?
|
| Acute Lung Injury | 2 | 2017 | 305 | 0.370 |
Why?
|
| Phosphorylation | 16 | 2020 | 1707 | 0.370 |
Why?
|
| Bone Marrow Cells | 10 | 2012 | 321 | 0.360 |
Why?
|
| Dendritic Cells | 3 | 2013 | 499 | 0.360 |
Why?
|
| Neutrophils | 9 | 2018 | 1124 | 0.350 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 20 | 0.340 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2010 | 4 | 0.330 |
Why?
|
| Lung Diseases | 4 | 2013 | 780 | 0.330 |
Why?
|
| beta-Glucans | 5 | 1993 | 16 | 0.320 |
Why?
|
| Up-Regulation | 4 | 2012 | 847 | 0.320 |
Why?
|
| Humans | 65 | 2026 | 145475 | 0.320 |
Why?
|
| Nitric Oxide | 5 | 2010 | 892 | 0.320 |
Why?
|
| Phagocytosis | 8 | 2012 | 296 | 0.320 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 167 | 0.310 |
Why?
|
| Enzyme Activation | 13 | 2011 | 762 | 0.310 |
Why?
|
| Actins | 6 | 2026 | 425 | 0.300 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 2883 | 0.300 |
Why?
|
| X-Ray Microtomography | 2 | 2021 | 108 | 0.300 |
Why?
|
| RNA, Messenger | 18 | 2011 | 2803 | 0.300 |
Why?
|
| Silicosis | 2 | 2023 | 30 | 0.290 |
Why?
|
| Transcription, Genetic | 6 | 2014 | 1454 | 0.290 |
Why?
|
| Testosterone | 1 | 2013 | 416 | 0.290 |
Why?
|
| Calcium | 3 | 2010 | 1190 | 0.290 |
Why?
|
| Bronchoalveolar Lavage Fluid | 7 | 2011 | 638 | 0.290 |
Why?
|
| Lung Compliance | 3 | 2014 | 42 | 0.280 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 506 | 0.270 |
Why?
|
| Cytokines | 8 | 2018 | 2067 | 0.270 |
Why?
|
| Gene Expression Regulation | 8 | 2010 | 2597 | 0.270 |
Why?
|
| Poly I-C | 6 | 1994 | 58 | 0.260 |
Why?
|
| Interleukin-13 | 2 | 2010 | 146 | 0.260 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 22 | 0.260 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 2 | 1999 | 18 | 0.260 |
Why?
|
| Chemokines | 2 | 2006 | 217 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 5 | 2008 | 1246 | 0.250 |
Why?
|
| Respiratory Mucosa | 5 | 2025 | 322 | 0.250 |
Why?
|
| Autoimmunity | 1 | 2013 | 933 | 0.250 |
Why?
|
| Inflammation | 8 | 2024 | 2878 | 0.250 |
Why?
|
| Transcription Factor AP-1 | 2 | 2006 | 79 | 0.250 |
Why?
|
| Male | 30 | 2026 | 72843 | 0.250 |
Why?
|
| Lysosomes | 6 | 1993 | 131 | 0.240 |
Why?
|
| Pulmonary Alveoli | 4 | 2025 | 385 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2008 | 162 | 0.240 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.240 |
Why?
|
| Gene Expression | 5 | 2012 | 1476 | 0.240 |
Why?
|
| Th2 Cells | 2 | 2004 | 175 | 0.230 |
Why?
|
| Membrane Microdomains | 2 | 2004 | 34 | 0.230 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2010 | 49 | 0.230 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 53 | 0.230 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 9 | 2012 | 264 | 0.230 |
Why?
|
| Enzyme Induction | 8 | 2008 | 88 | 0.230 |
Why?
|
| MAP Kinase Kinase 1 | 6 | 2001 | 70 | 0.220 |
Why?
|
| Sulfonamides | 2 | 2026 | 583 | 0.220 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 59 | 0.210 |
Why?
|
| Proline | 1 | 2005 | 82 | 0.210 |
Why?
|
| Recombinant Proteins | 6 | 2010 | 1368 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2020 | 1162 | 0.210 |
Why?
|
| Dual Specificity Phosphatase 1 | 3 | 2012 | 23 | 0.200 |
Why?
|
| Keratin-8 | 1 | 2023 | 4 | 0.200 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 5 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 425 | 0.200 |
Why?
|
| Models, Biological | 3 | 2025 | 1764 | 0.200 |
Why?
|
| Cellular Senescence | 1 | 2026 | 226 | 0.200 |
Why?
|
| Transfection | 5 | 2009 | 926 | 0.190 |
Why?
|
| Proteins | 5 | 2004 | 1023 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2004 | 166 | 0.190 |
Why?
|
| Growth Substances | 4 | 2004 | 138 | 0.190 |
Why?
|
| Respiratory System | 1 | 2024 | 150 | 0.190 |
Why?
|
| I-kappa B Proteins | 2 | 2012 | 75 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 4 | 2011 | 264 | 0.180 |
Why?
|
| Stem Cells | 2 | 2019 | 628 | 0.180 |
Why?
|
| Adenoma | 1 | 2004 | 218 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 273 | 0.180 |
Why?
|
| Complement Factor B | 5 | 1994 | 106 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2010 | 376 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 207 | 0.180 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1767 | 0.170 |
Why?
|
| Female | 25 | 2024 | 78845 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 263 | 0.170 |
Why?
|
| Cystic Fibrosis | 4 | 2008 | 1161 | 0.170 |
Why?
|
| Base Sequence | 8 | 2009 | 2170 | 0.170 |
Why?
|
| COS Cells | 5 | 2005 | 177 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2025 | 429 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 2129 | 0.170 |
Why?
|
| Lymph Nodes | 3 | 2013 | 503 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 1261 | 0.170 |
Why?
|
| Receptors, Cell Surface | 5 | 2009 | 372 | 0.160 |
Why?
|
| Mice, Mutant Strains | 3 | 2011 | 302 | 0.160 |
Why?
|
| Cell Communication | 2 | 2018 | 328 | 0.160 |
Why?
|
| Glucans | 6 | 1995 | 22 | 0.160 |
Why?
|
| Cell Differentiation | 5 | 2023 | 2046 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2011 | 1734 | 0.160 |
Why?
|
| Interferon-beta | 4 | 1994 | 92 | 0.150 |
Why?
|
| Reference Values | 2 | 2018 | 798 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2012 | 307 | 0.150 |
Why?
|
| Smoke | 2 | 2011 | 148 | 0.150 |
Why?
|
| Disease Progression | 3 | 2025 | 2864 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 1 | 4 | 2003 | 8 | 0.150 |
Why?
|
| Annexin A4 | 1 | 1999 | 4 | 0.150 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 23 | 0.150 |
Why?
|
| Cell Survival | 5 | 2013 | 1100 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 28 | 0.150 |
Why?
|
| Hydrogels | 2 | 2025 | 701 | 0.150 |
Why?
|
| Phosphatidylserines | 4 | 2008 | 62 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 2188 | 0.150 |
Why?
|
| HeLa Cells | 5 | 2013 | 632 | 0.140 |
Why?
|
| Fibrosis | 3 | 2019 | 559 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 64 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 82 | 0.140 |
Why?
|
| Cell Membrane | 4 | 2010 | 707 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2018 | 618 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 185 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3623 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 456 | 0.130 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1997 | 20 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1716 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2001 | 318 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 362 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 2019 | 562 | 0.130 |
Why?
|
| Kinetics | 6 | 2004 | 1567 | 0.120 |
Why?
|
| Sex Characteristics | 2 | 2013 | 782 | 0.120 |
Why?
|
| Homeostasis | 1 | 2020 | 642 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 855 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 637 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 848 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 740 | 0.120 |
Why?
|
| Protein Transport | 4 | 2011 | 442 | 0.110 |
Why?
|
| NADPH Oxidases | 3 | 2010 | 122 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 2664 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 1997 | 309 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 820 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 88 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2005 | 1480 | 0.110 |
Why?
|
| Platelet Activating Factor | 2 | 1995 | 45 | 0.110 |
Why?
|
| Blotting, Western | 6 | 2015 | 1179 | 0.110 |
Why?
|
| Fas Ligand Protein | 2 | 2013 | 61 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 296 | 0.110 |
Why?
|
| Permeability | 2 | 2017 | 169 | 0.110 |
Why?
|
| Asbestos | 2 | 1993 | 36 | 0.110 |
Why?
|
| Biomarkers | 2 | 2024 | 4295 | 0.100 |
Why?
|
| Hyaluronic Acid | 2 | 1994 | 226 | 0.100 |
Why?
|
| Hydroxyproline | 1 | 2014 | 18 | 0.100 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 12 | 0.100 |
Why?
|
| Binding Sites | 2 | 2010 | 1310 | 0.100 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 25 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 2005 | 190 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 208 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 371 | 0.100 |
Why?
|
| Interferons | 2 | 1998 | 186 | 0.100 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2005 | 9 | 0.100 |
Why?
|
| Consensus Sequence | 2 | 2005 | 73 | 0.100 |
Why?
|
| Bronchiolitis Obliterans | 1 | 1994 | 61 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 440 | 0.100 |
Why?
|
| Endocytosis | 2 | 2011 | 168 | 0.100 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 15 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 624 | 0.100 |
Why?
|
| Risk Factors | 3 | 2024 | 10885 | 0.100 |
Why?
|
| Remission Induction | 1 | 2014 | 307 | 0.100 |
Why?
|
| Fibronectins | 1 | 1994 | 136 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 5 | 2012 | 1041 | 0.100 |
Why?
|
| Proteolysis | 1 | 2013 | 172 | 0.100 |
Why?
|
| Extracellular Vesicles | 1 | 2015 | 171 | 0.090 |
Why?
|
| Cytoplasm | 2 | 2005 | 254 | 0.090 |
Why?
|
| Chemokine CXCL1 | 2 | 2011 | 76 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2003 | 354 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1994 | 251 | 0.090 |
Why?
|
| Anthrax | 1 | 2012 | 9 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 13 | 0.090 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 372 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 189 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 377 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2012 | 81 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 27 | 0.090 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2012 | 61 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 291 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 138 | 0.080 |
Why?
|
| Okadaic Acid | 2 | 2001 | 15 | 0.080 |
Why?
|
| Microscopy, Electron | 3 | 2015 | 414 | 0.080 |
Why?
|
| Leukotrienes | 1 | 1991 | 28 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2011 | 115 | 0.080 |
Why?
|
| Receptors, Lipoprotein | 1 | 1991 | 15 | 0.080 |
Why?
|
| Peritonitis | 2 | 2010 | 83 | 0.080 |
Why?
|
| Wound Healing | 2 | 2017 | 355 | 0.080 |
Why?
|
| Oxidative Stress | 3 | 2015 | 1356 | 0.080 |
Why?
|
| Receptors, IgG | 3 | 2009 | 77 | 0.080 |
Why?
|
| Chemokine CXCL2 | 2 | 2010 | 41 | 0.080 |
Why?
|
| Pyridones | 1 | 2012 | 209 | 0.080 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2011 | 71 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 538 | 0.080 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2011 | 118 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 1991 | 119 | 0.080 |
Why?
|
| Schistosoma mansoni | 1 | 2010 | 41 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2011 | 207 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 135 | 0.080 |
Why?
|
| Protein Binding | 5 | 2013 | 2238 | 0.080 |
Why?
|
| Schistosomiasis | 1 | 2010 | 50 | 0.080 |
Why?
|
| Granuloma | 1 | 2010 | 97 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 159 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2017 | 2507 | 0.080 |
Why?
|
| Nitrites | 2 | 2001 | 87 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2014 | 716 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 345 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 139 | 0.070 |
Why?
|
| NIH 3T3 Cells | 2 | 2014 | 146 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 178 | 0.070 |
Why?
|
| Antigens | 1 | 2011 | 348 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 686 | 0.070 |
Why?
|
| Elastin | 1 | 2009 | 78 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 124 | 0.070 |
Why?
|
| Asthma | 2 | 2012 | 1797 | 0.070 |
Why?
|
| Mutation | 4 | 2008 | 4075 | 0.070 |
Why?
|
| Mitochondria | 1 | 2015 | 992 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 174 | 0.070 |
Why?
|
| Myoblasts | 1 | 2009 | 83 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 308 | 0.070 |
Why?
|
| Interleukin-1 | 3 | 2001 | 961 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2009 | 83 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2011 | 254 | 0.070 |
Why?
|
| Vitamin D | 1 | 2012 | 403 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2001 | 149 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2012 | 531 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 381 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2005 | 471 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 325 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 118 | 0.070 |
Why?
|
| Time Factors | 3 | 2014 | 7123 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 389 | 0.060 |
Why?
|
| Prednisone | 1 | 2008 | 224 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 82 | 0.060 |
Why?
|
| Interferon Type I | 1 | 1988 | 147 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 1998 | 41 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2014 | 277 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 713 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 477 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1997 | 57 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 870 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2012 | 517 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2090 | 0.060 |
Why?
|
| Vaccines | 1 | 2011 | 388 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2011 | 335 | 0.060 |
Why?
|
| Middle Aged | 8 | 2012 | 36215 | 0.060 |
Why?
|
| Glucuronidase | 3 | 1993 | 27 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 21 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2026 | 143 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 63 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2012 | 89 | 0.060 |
Why?
|
| Asparagine | 1 | 2005 | 35 | 0.060 |
Why?
|
| Sp3 Transcription Factor | 1 | 2005 | 6 | 0.060 |
Why?
|
| Sex Factors | 1 | 2011 | 2105 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2004 | 306 | 0.050 |
Why?
|
| Golgi Apparatus | 2 | 2005 | 99 | 0.050 |
Why?
|
| Antibodies | 2 | 1998 | 397 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2025 | 247 | 0.050 |
Why?
|
| Luciferases | 1 | 2005 | 153 | 0.050 |
Why?
|
| Colorado | 1 | 2015 | 4554 | 0.050 |
Why?
|
| Dinoprostone | 3 | 1995 | 180 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 143 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 112 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 1991 | 1164 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2004 | 177 | 0.050 |
Why?
|
| Point Mutation | 1 | 2005 | 240 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 302 | 0.050 |
Why?
|
| Phenotype | 4 | 2019 | 3155 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 977 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2013 | 666 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2004 | 32 | 0.050 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 35 | 0.050 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 2 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 14 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 4 | 1999 | 1505 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 24 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 140 | 0.050 |
Why?
|
| Age Factors | 1 | 2011 | 3342 | 0.050 |
Why?
|
| Exons | 1 | 2005 | 363 | 0.050 |
Why?
|
| Blood Proteins | 2 | 2001 | 239 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 66 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1991 | 1048 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 2953 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1993 | 85 | 0.050 |
Why?
|
| Calcimycin | 2 | 1994 | 36 | 0.050 |
Why?
|
| Chromones | 1 | 2002 | 43 | 0.050 |
Why?
|
| Osmotic Pressure | 1 | 2002 | 41 | 0.050 |
Why?
|
| Silicon Dioxide | 1 | 2003 | 119 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 51 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 408 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2023 | 120 | 0.040 |
Why?
|
| Phosphoamino Acids | 1 | 2001 | 1 | 0.040 |
Why?
|
| Adenoviridae | 2 | 2014 | 199 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2001 | 5 | 0.040 |
Why?
|
| Beclomethasone | 1 | 2001 | 8 | 0.040 |
Why?
|
| Flavonoids | 1 | 2002 | 85 | 0.040 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2001 | 31 | 0.040 |
Why?
|
| Morpholines | 1 | 2002 | 130 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2013 | 115 | 0.040 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 8 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 76 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2158 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 50 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 22 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2001 | 47 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2001 | 100 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2001 | 55 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 119 | 0.040 |
Why?
|
| Rats | 3 | 2017 | 5584 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2014 | 391 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2001 | 139 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2025 | 649 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2011 | 8057 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 2378 | 0.040 |
Why?
|
| Aged | 4 | 2009 | 26153 | 0.040 |
Why?
|
| Hydrolases | 2 | 1993 | 40 | 0.040 |
Why?
|
| Phosphopeptides | 1 | 2000 | 19 | 0.040 |
Why?
|
| Caspases | 1 | 2001 | 233 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 2000 | 62 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 66 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2001 | 295 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 2 | 2010 | 32 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2000 | 41 | 0.040 |
Why?
|
| Imidazoles | 1 | 2001 | 247 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2000 | 312 | 0.040 |
Why?
|
| Transcriptome | 1 | 2026 | 1038 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 144 | 0.040 |
Why?
|
| Sepharose | 1 | 1999 | 32 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 1998 | 1 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 387 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 3116 | 0.040 |
Why?
|
| Adult | 8 | 2012 | 40777 | 0.040 |
Why?
|
| Indomethacin | 2 | 1991 | 76 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 156 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 1957 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 574 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 273 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 123 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 387 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 66 | 0.030 |
Why?
|
| Dexamethasone | 2 | 2012 | 365 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 749 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 43 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 1997 | 6 | 0.030 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 68 | 0.030 |
Why?
|
| DNA Probes | 1 | 1997 | 59 | 0.030 |
Why?
|
| Phospholipids | 1 | 1999 | 214 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1998 | 405 | 0.030 |
Why?
|
| Adaptation, Physiological | 2 | 1995 | 560 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2008 | 776 | 0.030 |
Why?
|
| Regeneration | 1 | 2019 | 197 | 0.030 |
Why?
|
| Cilia | 1 | 1998 | 173 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 611 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 447 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2017 | 86 | 0.030 |
Why?
|
| Cell Division | 1 | 1998 | 756 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 91 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 305 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 499 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 728 | 0.030 |
Why?
|
| Pyridines | 1 | 2001 | 609 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1998 | 203 | 0.030 |
Why?
|
| Complement C3 | 2 | 1988 | 187 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 376 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 2524 | 0.030 |
Why?
|
| Arrestins | 1 | 2015 | 14 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 1995 | 10 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 777 | 0.030 |
Why?
|
| Cell Movement | 2 | 2013 | 959 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1997 | 376 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2382 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 45 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1995 | 53 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1997 | 312 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1997 | 1001 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 1995 | 75 | 0.030 |
Why?
|
| Eosinophils | 1 | 1997 | 316 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 119 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 73 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 552 | 0.030 |
Why?
|
| Exosomes | 1 | 2015 | 104 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1995 | 316 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 193 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2930 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2013 | 15 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 55 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 104 | 0.030 |
Why?
|
| Forecasting | 1 | 1995 | 390 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1300 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 54 | 0.020 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 1991 | 9 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2013 | 45 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1995 | 231 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 1993 | 89 | 0.020 |
Why?
|
| Eicosanoids | 1 | 1993 | 58 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 276 | 0.020 |
Why?
|
| Culture Media | 1 | 2013 | 161 | 0.020 |
Why?
|
| Zymosan | 2 | 2010 | 39 | 0.020 |
Why?
|
| Polyglactin 910 | 1 | 2012 | 6 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1994 | 294 | 0.020 |
Why?
|
| PPAR delta | 1 | 2012 | 6 | 0.020 |
Why?
|
| Endothelium | 1 | 2013 | 119 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 981 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 166 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2012 | 48 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 18 | 0.020 |
Why?
|
| Cell Separation | 1 | 1993 | 305 | 0.020 |
Why?
|
| Diterpenes | 1 | 2012 | 26 | 0.020 |
Why?
|
| Ionomycin | 1 | 1992 | 22 | 0.020 |
Why?
|
| Prone Position | 1 | 2012 | 25 | 0.020 |
Why?
|
| Receptors, CCR7 | 1 | 2012 | 32 | 0.020 |
Why?
|
| Supine Position | 1 | 2012 | 37 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1993 | 319 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 407 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 66 | 0.020 |
Why?
|
| Young Adult | 1 | 2009 | 14219 | 0.020 |
Why?
|
| Anions | 1 | 1991 | 29 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 1994 | 163 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 84 | 0.020 |
Why?
|
| Berylliosis | 1 | 1994 | 202 | 0.020 |
Why?
|
| Aldehydes | 1 | 2012 | 139 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 364 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 132 | 0.020 |
Why?
|
| Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3922 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2011 | 20 | 0.020 |
Why?
|
| Staurosporine | 1 | 2011 | 22 | 0.020 |
Why?
|
| Instillation, Drug | 1 | 2011 | 9 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 56 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 2012 | 123 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 130 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 22530 | 0.020 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 1991 | 3 | 0.020 |
Why?
|
| SRS-A | 1 | 1991 | 17 | 0.020 |
Why?
|
| Asbestos, Serpentine | 1 | 1991 | 5 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 129 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1991 | 396 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 1991 | 79 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 1991 | 14 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 1991 | 22 | 0.020 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1991 | 34 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1992 | 166 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 131 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1990 | 50 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1991 | 82 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2010 | 8 | 0.020 |
Why?
|
| Phospholipases A | 1 | 1991 | 97 | 0.020 |
Why?
|
| Sputum | 1 | 2012 | 302 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1990 | 73 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2012 | 265 | 0.020 |
Why?
|
| Benzoquinones | 1 | 1991 | 46 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1990 | 52 | 0.020 |
Why?
|
| Phagosomes | 1 | 1990 | 40 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 77 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 42 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 37 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 267 | 0.020 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2009 | 9 | 0.020 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 200 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 52 | 0.020 |
Why?
|
| Amiloride | 1 | 2009 | 25 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 2028 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 50 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 219 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 200 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 254 | 0.020 |
Why?
|
| Survivors | 1 | 2013 | 523 | 0.020 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 19 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2009 | 76 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 526 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 51 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 365 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 44 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 211 | 0.020 |
Why?
|
| Immune Sera | 1 | 1988 | 77 | 0.020 |
Why?
|
| Skin | 1 | 2013 | 753 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 1988 | 76 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 253 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 148 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2008 | 145 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 158 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2008 | 130 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 487 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 494 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 407 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 886 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 1986 | 14 | 0.020 |
Why?
|
| Hexosaminidases | 1 | 1986 | 17 | 0.010 |
Why?
|
| Risk | 1 | 2009 | 919 | 0.010 |
Why?
|
| Methylamines | 1 | 1986 | 39 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1986 | 114 | 0.010 |
Why?
|
| COP-Coated Vesicles | 1 | 2005 | 2 | 0.010 |
Why?
|
| Tubercidin | 1 | 1985 | 1 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1985 | 12 | 0.010 |
Why?
|
| Esterases | 1 | 1985 | 9 | 0.010 |
Why?
|
| ADAM17 Protein | 1 | 2005 | 42 | 0.010 |
Why?
|
| Threonine | 1 | 2005 | 44 | 0.010 |
Why?
|
| Receptors, Purinergic | 1 | 1985 | 20 | 0.010 |
Why?
|
| Theophylline | 1 | 1985 | 41 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2005 | 64 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 546 | 0.010 |
Why?
|
| Homocysteine | 1 | 1985 | 152 | 0.010 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cell Surface Extensions | 1 | 2004 | 13 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1985 | 563 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 972 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 92 | 0.010 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 56 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 63 | 0.010 |
Why?
|
| Adenosine | 1 | 1985 | 255 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 748 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 452 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 6447 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 192 | 0.010 |
Why?
|
| Adenine | 1 | 1985 | 339 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1407 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1443 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 6013 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 38 | 0.010 |
Why?
|
| Microtubules | 1 | 2004 | 265 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2001 | 62 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 307 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 331 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 428 | 0.010 |
Why?
|
| Infant | 1 | 1995 | 10077 | 0.010 |
Why?
|
| Quality of Life | 1 | 2013 | 3204 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2001 | 227 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 571 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 782 | 0.010 |
Why?
|
| Glucan Endo-1,3-beta-D-Glucosidase | 1 | 1998 | 1 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 1067 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 31 | 0.010 |
Why?
|
| Bucladesine | 1 | 1995 | 19 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1995 | 42 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 23 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 1891 | 0.010 |
Why?
|
| Child | 2 | 2008 | 22707 | 0.010 |
Why?
|
| Leukotriene C4 | 1 | 1993 | 6 | 0.010 |
Why?
|
| Peritoneal Lavage | 1 | 1993 | 8 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1993 | 14 | 0.010 |
Why?
|
| Diamide | 1 | 1993 | 4 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 102 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1993 | 182 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 505 | 0.010 |
Why?
|
| Epoprostenol | 1 | 1993 | 132 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 5423 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1993 | 435 | 0.000 |
Why?
|
| Mannans | 1 | 1986 | 5 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1986 | 112 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2001 | 11772 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 11853 | 0.000 |
Why?
|